Word

SELECT

Status

Pending

Status Code

688

Status Date

Tuesday, April 2, 2024

Serial Number

97551508

Mark Type

5000

Filing Date

Tuesday, August 16, 2022

Published for Opposition

Tuesday, February 6, 2024

Trademark Owner History

Olympus Corporation - Owner At Publication

Classifications

9 Downloadable reports and documents in the field of pulmonary medicine, pulmonary disease and pulmonary conditions; downloadable reports and documents featuring surgical and medical information in the field of pulmonary medicine, pulmonary disease and pulmonary conditions; downloadable reports and documents featuring surgical information, medical information, and quantitative measures for use in connection with the evaluation and treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions; downloadable reports and documents featuring surgical information, medical information, and quantitative measures for use in connection with the visual readings of lung structures; downloadable reports and documents featuring surgical information, medical information, and quantitative measures for use in confirming the eligibility of patients and the identification of correct target lobes for endobronchial valve treatment; downloadable reports and documents featuring information about medical devices and medical procedures for use in connection with the evaluation and treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions and emphysema disease

16 Printed materials, namely, printed reports and printed medical records comprising analyses of results of medical diagnostic testing in the field of pulmonary medicine, pulmonary disease and pulmonary conditions; printed materials, namely, printed reports and printed medical records comprising analyses of results of medical diagnostic testing featuring surgical and medical information in the field of pulmonary medicine, pulmonary disease and pulmonary conditions; printed materials, namely, printed reports and printed medical records comprising analyses of results of medical diagnostic testing featuring surgical information, medical information, and quantitative measures for use in connection with the evaluation, surgical treatment, and medical treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions and emphysema disease; printed materials, namely, printed reports and printed medical records comprising analyses of results of medical diagnostic testing in the field of pulmonary medicine and quantitative computed tomography analysis; printed materials, namely, printed reports and printed medical records comprising analyses of results of medical diagnostic testing in the field of pulmonary medicine featuring surgical information, medical information, and quantitative measures to support visual readings of lung structures; printed materials, namely, printed reports and printed medical records comprising analyses of results of medical diagnostic testing in the field of pulmonary medicine featuring surgical information, medical information, and quantitative measures for use in confirming the eligibility of patients and the identification of correct target lobes for endobronchial valve treatment; printed materials, namely, printed reports and printed medical records comprising analyses of results of medical diagnostic testing featuring information about medical devices and medical procedures for use in connection with the evaluation and treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions and emphysema disease

44 Providing medical information regarding medical devices for the treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions, and emphysema disease; medical diagnostic testing, monitoring and reporting services in the field of pulmonary medicine, pulmonary disease and pulmonary conditions; medical information services, namely, analysis and reporting services relating to the treatment of patients based on quantitative measurements of computed tomography scans in the field of pulmonary medicine, pulmonary disease and pulmonary conditions; providing online medical record analysis services designed to provide patients and practitioners with customized data used to inform and recommend treatment options in the field of pulmonary medicine, pulmonary disease and pulmonary conditions; providing a website featuring online medical information regarding medical devices and medical procedures for use in connection with the evaluation and treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions, and emphysema disease

42 Providing temporary use of online non-downloadable software for quantitative computed tomography analysis in the field of pulmonary medicine and pulmonary disease, and generating reports corresponding to the foregoing; providing temporary use of online non-downloadable software featuring artificial intelligence for quantitative computed tomography analysis in the field of pulmonary medicine and pulmonary disease, and generating reports corresponding to the foregoing; providing temporary use of on-line non-downloadable software for analyzing patient data in the field of pulmonary medicine and the evaluation and treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions, and emphysema disease and generating reports corresponding to the foregoing; software as a service (SAAS) services featuring software for analyzing patient data in the field of pulmonary medicine and the evaluation and treatment of chronic obstructive pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions, and emphysema disease, and generating reports corresponding to the foregoing; software as a services (SAAS) services featuring software for quantitative data analysis of computed tomography scans and generating corresponding reports, all in the field of pulmonary medicine; software as a services (SAAS) services featuring software using artificial intelligence for quantitative data analysis of computed tomography scans and generating corresponding reports, all in the field of pulmonary medicine; software as a services (SAAS) services featuring temporary use of non-downloadable software for use in securely accessing and submitting medical information in the form of computed tomography scans, receiving quantitative data analysis of computed tomography scans, and generating corresponding reports, all in the field of pulmonary medicine; software as a services (SAAS) services featuring temporary use of non-downloadable software for use in securely accessing surgical information, medical information, and quantitative measures to support visual readings of lung structures, all in the field of pulmonary medicine; software as a services (SAAS) services featuring temporary use of non-downloadable software for use in securely accessing surgical information, medical information, and quantitative measures for use in confirming the eligibility of patients and the identification of correct target lobes for endobronchial valve treatment; software as a services (SAAS) services featuring temporary use of non-downloadable software for use in securely accessing information about medical devices and medical procedures for use in connection with the evaluation and treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions, and emphysema disease

The mark consists of the wording "SeleCT" in which the initial letter "S" is rendered as a capital letter and the last two letters "CT" are rendered in capital letters, while the other letters are rendered in lowercase.
Color is not claimed as a feature of the mark.

Trademark Events

Apr 2, 2024

Noa E-Mailed - Sou Required From Applicant

Feb 6, 2024

Official Gazette Publication Confirmation E-Mailed

Feb 6, 2024

Published For Opposition

Jan 17, 2024

Notification Of Notice Of Publication E-Mailed

Dec 31, 2023

Approved For Pub - Principal Register

Dec 21, 2023

Teas/Email Correspondence Entered

Dec 21, 2023

Correspondence Received In Law Office

Dec 21, 2023

Teas Response To Suspension Inquiry Received

Dec 11, 2023

Report Completed Suspension Check Case Still Suspended

Jun 13, 2023

Notification Of Letter Of Suspension E-Mailed

Jun 13, 2023

Letter Of Suspension E-Mailed

Jun 13, 2023

Suspension Letter Written

Jun 13, 2023

Examiner's Amendment Entered

Jun 13, 2023

Notification Of Examiners Amendment E-Mailed

Jun 13, 2023

Examiners Amendment E-Mailed

Jun 13, 2023

Examiners Amendment -Written

Jun 2, 2023

Assigned To Examiner

Sep 7, 2022

New Application Office Supplied Data Entered

Aug 19, 2022

New Application Entered